Robotic Arm-Assisted Technology Provides Surgeons With
Consistently Reproducible Precision in Hip Replacement Surgery
MAKOplasty Total Hip Arthroplasty is Designed to Help Surgeons Restore Patient Mobility and Lifestyle
FT. LAUDERDALE, Fla.,
MAKO's total hip replacement application is designed to support the surgeon's ability to more accurately align and position the implants relative to the needs of a patient. This may reduce potential complications associated with conventional hip replacement surgery. MAKOplasty Total Hip Arthroplasty provides a surgeon with a pre-operative 3-D reconstruction of the patient's hip and is used to develop the patient-specific surgical plan. The robotic-arm then assists the surgeon during the procedure to accurately prepare the joint and optimally place hip implants.
"MAKOplasty Total Hip Arthroplasty provides a significant advantage to me as a surgeon and to my patients. It provides quantitative knowledge for what were difficult judgment decisions inherent in manually performed operations," said
A recently published
"We're pleased to introduce MAKOplasty Total Hip Arthroplasty as an option for surgeons who perform total hip replacement," said Maurice R. Ferrė, M.D., president and chief executive officer of
According to a
"With my hip pain, I really couldn't walk or sleep, and going up and down stairs was very painful," said
Approximately 10 million Americans suffer from osteoarthritis (OA) of the hip, or the wearing away of the cartilage that cushions the bones of the hips, causing hip pain and stiffness, which can affect mobility, including walking and bending. Hip OA is the most common cause of hip replacement surgery.3
MAKOplasty Total Hip Arthroplasty is the newest application for MAKO's RIO robotic arm system and builds upon five years of MAKO's existing MAKOplasty Partial Knee Resurfacing procedure for patients with early to mid-stage osteoarthritis of the knee. MAKOplasty Total Hip Arthroplasty was cleared for use in the U.S. by the
This press release contains forward-looking statements regarding, among other things, statements related to expectations, goals, plans, objectives and future events. MAKO intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934 and the Private Securities Reform Act of 1995. In some cases, forward-looking statements can be identified by the following words: "may," "will," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements are based on the current estimates and assumptions of our management as of the date of this press release
and are subject to risks, uncertainties, changes in circumstances, assumptions and other factors that may cause actual results to differ materially from those indicated by forward-looking statements, many of which are beyond MAKO's ability to control or predict. Such factors, among others, may have a material adverse effect on MAKO's business, financial condition and results of operations and may include the potentially significant impact of a continued economic downturn or delayed economic recovery on the ability of MAKO's customers to secure adequate funding, including access to credit, for the purchase of MAKO's products or cause MAKO's customers to delay a purchasing decision, changes in competitive conditions and prices in MAKO's markets, unanticipated issues relating to intended product launches, decreases in sales of MAKO's principal product lines, increases in expenditures
related to increased or changing governmental regulation or taxation of MAKO's business, unanticipated issues in complying with regulatory requirements related to MAKO's current products or securing regulatory clearance or approvals for new products or upgrades or changes to MAKO's current products, the impact of the recently enacted
MAKO does and seeks to do engage healthcare professionals and entities in the development and improvement of our products. Our policy statement and roster of healthcare professional partners are available at http://www.makosurgical.com/site/index.php/company/business-conduct-2.
"MAKOplasty®," "RESTORIS®," and "RIO®," as well as the "MAKO" logo, whether standing alone or in connection with the words "
2 Survey conducted by phone within
3 AAOS Website http://orthoinfo.aaos.org/topic.cfm?topic=a00377
CONTACT: MEDIA CONTACTS:Source:
Yvette Cuello MAKO Surgical Corp.954-609-5085 firstname.lastname@example.org Cynthia Kalb MAKO Surgical Corp.954-218-9133 email@example.com Lily EngWeber Shandwick 415-262-5966 firstname.lastname@example.org INVESTOR CONTACTS: Susan Verde MAKO Surgical Corp.954-628-1706 email@example.com or Mark Klausner Westwicke Partners443-213-0500 firstname.lastname@example.org
News Provided by Acquire Media